81 related articles for article (PubMed ID: 25269647)
41. Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials.
Rahman HS; Rasedee A; Yeap SK; Othman HH; Chartrand MS; Namvar F; Abdul AB; How CW
Biomed Res Int; 2014; 2014():920742. PubMed ID: 25025076
[TBL] [Abstract][Full Text] [Related]
42. Transmembrane protein 25 abrogates monomeric EGFR-driven STAT3 activation in triple-negative breast cancer.
Mohan CD; Rangappa KS; Sethi G
MedComm (2020); 2024 Apr; 5(4):e492. PubMed ID: 38532948
[TBL] [Abstract][Full Text] [Related]
43. Perspectives of CD44 targeting therapies.
Orian-Rousseau V; Ponta H
Arch Toxicol; 2015 Jan; 89(1):3-14. PubMed ID: 25472903
[TBL] [Abstract][Full Text] [Related]
44. CD44: A New Prognostic Marker in Colorectal Cancer?
Ziranu P; Pretta A; Aimola V; Cau F; Mariani S; D'Agata AP; Codipietro C; Rizzo D; Dell'Utri V; Sanna G; Moledda G; Cadoni A; Lai E; Puzzoni M; Pusceddu V; Castagnola M; Scartozzi M; Faa G
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672650
[TBL] [Abstract][Full Text] [Related]
45. Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives.
Soroush A; Pourhossein S; Hosseingholizadeh D; Hjazi A; Shahhosseini R; Kavoosi H; Kermanshahi N; Behnamrad P; Ghavamikia N; Dadashpour M; Karkon Shayan S
Med Oncol; 2024 Apr; 41(5):125. PubMed ID: 38652207
[TBL] [Abstract][Full Text] [Related]
46. CD44 In Sarcomas: A Comprehensive Review and Future Perspectives.
Fernández-Tabanera E; Melero-Fernández de Mera RM; Alonso J
Front Oncol; 2022; 12():909450. PubMed ID: 35785191
[TBL] [Abstract][Full Text] [Related]
47. CD44: A Multifunctional Mediator of Cancer Progression.
Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493
[TBL] [Abstract][Full Text] [Related]
48. Trefoil Factor 3 Inhibits Thyroid Cancer Cell Progression Related to IL-6/JAK/STAT3 Signaling Pathway.
Xin Y; Shang X; Sun X; Liu Y; Xu G; Xue G
Evid Based Complement Alternat Med; 2021; 2021():2130229. PubMed ID: 34567204
[TBL] [Abstract][Full Text] [Related]
49. CD44 in Ovarian Cancer Progression and Therapy Resistance-A Critical Role for STAT3.
Martincuks A; Li PC; Zhao Q; Zhang C; Li YJ; Yu H; Rodriguez-Rodriguez L
Front Oncol; 2020; 10():589601. PubMed ID: 33335857
[TBL] [Abstract][Full Text] [Related]
50. Deoxycholic Acid Upregulates the Reprogramming Factors KFL4 and OCT4 Through the IL-6/STAT3 Pathway in Esophageal Adenocarcinoma Cells.
Chen M; Ye A; Wei J; Wang R; Poon K
Technol Cancer Res Treat; 2020; 19():1533033820945302. PubMed ID: 32869704
[TBL] [Abstract][Full Text] [Related]
51. CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells.
Yin J; Zhang H; Wu X; Zhang Y; Li J; Shen J; Zhao Y; Xiao Z; Lu L; Huang C; Zhang Z; Du F; Wu Y; Kaboli PJ; Cho CH; Yuan D; Li M
Int J Mol Med; 2020 Jun; 45(6):1783-1792. PubMed ID: 32236608
[TBL] [Abstract][Full Text] [Related]
52. Gingers and Their Purified Components as Cancer Chemopreventative Agents.
Lechner JF; Stoner GD
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394732
[TBL] [Abstract][Full Text] [Related]
53. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
[TBL] [Abstract][Full Text] [Related]
54. Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase.
Han J; Lim W; You D; Jeong Y; Kim S; Lee JE; Shin TH; Lee G; Park S
J Oncol; 2019; 2019():1345026. PubMed ID: 31275376
[TBL] [Abstract][Full Text] [Related]
55. Potential of Zerumbone as an Anti-Cancer Agent.
Girisa S; Shabnam B; Monisha J; Fan L; Halim CE; Arfuso F; Ahn KS; Sethi G; Kunnumakkara AB
Molecules; 2019 Feb; 24(4):. PubMed ID: 30781671
[TBL] [Abstract][Full Text] [Related]
56. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.
Wang Z; Zhao K; Hackert T; Zöller M
Front Cell Dev Biol; 2018; 6():97. PubMed ID: 30211160
[TBL] [Abstract][Full Text] [Related]
57. The biology and role of CD44 in cancer progression: therapeutic implications.
Chen C; Zhao S; Karnad A; Freeman JW
J Hematol Oncol; 2018 May; 11(1):64. PubMed ID: 29747682
[TBL] [Abstract][Full Text] [Related]
58. A Review of the Biomedical Applications of Zerumbone and the Techniques for Its Extraction from Ginger Rhizomes.
Kalantari K; Moniri M; Boroumand Moghaddam A; Abdul Rahim R; Bin Ariff A; Izadiyan Z; Mohamad R
Molecules; 2017 Sep; 22(10):. PubMed ID: 28974019
[TBL] [Abstract][Full Text] [Related]
59. Possible Anticancer Mechanisms of Some Costus speciosus Active Ingredients Concerning Drug Discovery.
El-Far AH; Badria FA; Shaheen HM
Curr Drug Discov Technol; 2016; 13(3):123-143. PubMed ID: 27515456
[TBL] [Abstract][Full Text] [Related]
60. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
